Search for: "Mallinckrodt, LLC" Results 1 - 20 of 20
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Mar 2020, 9:55 pm by Patent Docs
Noonan -- Mallinckrodt filed a certiorari petition with the Supreme Court last week, over the Federal Circuit panel decision (by Chief Judge Prost joined by Judge Dyk; Judge Newman dissented on the issue before the Court in this petition) affirming dismissal of a suit by Mallinckrodt's subsidiary, iNO Pharmaceuticals, in iNO Therapeutics LLC v. [read post]
19 Jul 2013, 4:35 pm by Greene LLP
Pharmaceutical manufacturer Mallinckrodt LLC has agreed to pay $3.5 million to settle allegations that it made illegal payments to physicians to prescribe anti-depressants and sleep aids produced by the company. [read post]
11 Jul 2017, 1:20 pm by Jeffrey A. Newman
Mallinckrodt LLC, pharmaceutical manufacturer and one of the largest producers of oxycodone will pay $35 Million settling assertions that it violated the Controlled Substances Act (CSA) says the DOJ. [read post]
6 Sep 2019, 9:38 am by luiza
This week, the Department of Justice announced that pharmaceutical company Mallinckrodt ARD LLC had agreed to pay over $15 million to resolve allegations that it paid illegal kickbacks to physicians to induce them to prescribe Acthar. [read post]
6 May 2019, 9:58 pm by Patent Docs
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
10 Jun 2019, 10:58 am by Andrew Murray
On June 5, 2019, the Department of Justice announced that the United States has filed a complaint against pharmaceutical company, Mallinckrodt ARD LLC, alleging False Claims Act violations stemming from kickbacks related to the drug, Acthar Gel. [read post]
5 Jun 2019, 11:25 am by Jeffrey A. Newman
The United States filed a complaint under the False Claims Act against Mallinckrodt ARD LLC, formerly known as Questcor Pharmaceuticals, Inc. [read post]
30 Oct 2017, 3:46 pm by Baum Hedlund
The plaintiffs in the Acthar class action are MSP Recovery Claims (MSP = Medicare Secondary Payer), Series LLC of Delaware; MAO-MSO Recovery II, LLC of Delaware; MSP Recovery LLC of Florida; and MSPA Claims 1 LLC of Florida. [read post]
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
16 May 2019, 8:15 am by Stone Law, P.C.
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
20 Jul 2017, 6:58 pm by FDABlog HPM
– On July 11, 2017, the Department of Justice and the Drug Enforcement Administration (“DEA”) announced that Mallinckrodt LLC, a pharmaceutical manufacturer, agreed to pay $35 million to settle allegations related to the adequacy of its efforts to detect and inform DEA of suspicious orders of controlled substances. [read post]
28 Sep 2014, 9:59 pm by Patent Docs
InnoPharma Licensing LLC et al. 1:14-cv-01225; filed September 24, 2014 in the District Court of Delaware • Plaintiffs: Cadence Pharmaceuticals Inc.; SCR Pharmatop; Mallinckrodt IP • Defendants: InnoPharma Licensing LLC; InnoPharma Inc. [read post]
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
(collectively, “Actavis”) failed to prove by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals and Mallinckrodt LLC (collectively, “Endo”) were invalid. [read post]
8 Oct 2016, 3:25 am by Gregory B. Williams
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
9 Sep 2019, 2:30 am by Tinker Ready
Mallinckrodt ARD LLC will pay the federal government $15 million to resolve whistleblower allegations that the United Kingdom-based company wined and dined physicians to induce them to write prescriptions for the company’s pricey H.P. [read post]